Tag: Alzheimers

Part the First: Anti-amyloid Antibodies and Alzheimer’s Disease (AD).  A Cochrane review of monoclonal antibodies targeting amyloid plaques in AD ...

A total of 7.4 million Americans aged 65 and older are living with Alzheimer’s disease in 2026, an increase of ...

A simple finger prick could revolutionize how doctors diagnose Alzheimer’s disease, according to researchers at the University of Gothenburg in ...

This is an edition of the WSJ Weekend Reads newsletter, a weekly look at our most colorful, thought-provoking and original ...

For decades, Alzheimer’s disease could only be diagnosed after symptoms became obvious—memory loss, confusion, and cognitive decline. By then, damage ...

Few realities of aging are scarier than the possibility that you might someday be diagnosed with dementia. Such fears are ...

Forgetting where you left your keys isn’t unusual—but forgetting what they’re for can be. Alzheimer’s disease develops slowly, often years ...

More than 7.2 million people (5% of those 65-74 years old, 13% of those 75-84 years old, and 33% of ...

Dublin-based Aerska, a biotechnology company specialising in the treatment of neurological diseases, announced its launch along with $21M (approximately €17.8M) ...